Acylated piperidine derivatives as melanocortin-4 receptor agonists

Details for Australian Patent Application No. 2006297452 (hide)

Owner Merck & Co., Inc.

Inventors Hong, Qingmei; Bakshi, Raman K.; Nargund, Ravi P.

Agent Spruson & Ferguson

Pub. Number AU-A-2006297452

PCT Pub. Number WO2007/041061

Priority 60/722,173 30.09.05 US

Filing date 26 September 2006

Wipo publication date 12 April 2007

International Classifications

A61K 31/445 (2006.01) - Non-condensed piperidines, e.g. piperocaine

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

13 March 2008 PCT application entered the National Phase

  PCT publication WO2007/041061 Priority application(s): WO2007/041061

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

19 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006297462-5- (phenylisoxazolylethoxy) -triazol3 - yl substituted pyridine compounds for the treatment of neurological, psychiatric or pain disorders

2006297444-Formulation comprising metformin and vildagli ptin